Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancer

Author： Peng Zheng-Hong   Sima Monika   Salama Mohamed E.   Kopečková Pavla   Kopeček Jindřich  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.21, Iss.10, 2013-12, pp. : 968-980

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen

By  

Current Drug Targets, Vol. 10, Iss. 2, 2009-02 ,pp. : 118-125

Bentham Science Publishers

Access to resources Recommend Favorite

PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 8, 2013-01 ,pp. : 951-962

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen

By Slovin Susan F  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 561-570

Informa Healthcare

Access to resources Recommend Favorite

Prostate-specific antigen

By Ornstein D.K.   Pruthi R.S.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 7, 2000-12 ,pp. : 1399-1411

Informa Healthcare

Access to resources Recommend Favorite

Prostate Cancer Screening and Determining the Appropriate Prostate-Specific Antigen Cutoff Values

By Catalona William J.   Loeb Stacy  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 8, Iss. 2, 2010-02 ,pp. : 265-270

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite